Check the product and lot
Think You Received Recalled IV Saline? Check the Records
30-second answer
Contact the treating provider about medical concerns. Ask the facility whether your encounter can be linked to B. Braun NDC 0264-1800-32 and lot J6B435, J6B444, or J6B457. Request your records and preserve every response without assuming exposure.
Legal information from the Law Office of Arta Wildeboer · Updated
Do this now
- 1Contact the treating physician or healthcare provider about medical concerns. Give the facility, treatment date, department, procedure or infusion, and symptoms without diagnosing the cause yourself.
- 2Ask whether the encounter involved B. Braun 0.9% Sodium Chloride Injection USP, 100 mL in a 150 mL PAB container, catalog S8004-5264, or NDC 0264-1800-32.
- 3Ask whether pharmacy, barcode, cabinet, preparation, inventory, purchasing, or distributor records can connect the encounter to lot J6B435, J6B444, or J6B457.
- 4Request your medical and billing records through the facility's normal process. Ask for orders, medication-administration, nursing and infusion, procedure or anesthesia, discharge, portal, and patient-specific pharmacy records maintained with them. Ask separately where internal lot-tracing records are kept; an ordinary request may not reach inventory, purchasing, quality, peer-review, or risk-management material.
- 5Save recall notices, portal messages, letters, emails, call notes, record requests, responses, bills, and original files. Mark missing details as unknown instead of guessing.
Avoid this
- Do not change treatment, handle clinical products, enter medication storage, remove a bag or label, or demand facility property.
- Do not assume nationwide distribution means your facility used a recalled lot, or that a symptom proves exposure or causation.
- Do not treat a MedWatch report, facility notice, or recall as a finding of defect, negligence, injury, or legal responsibility.
Save these
- Facility, address, treatment date, department, bed or chair, procedure, infusion, and provider information
- Orders, medication administration records, nursing and infusion notes, pharmacy records, discharge papers, portal messages, and itemized bills
- Product name, catalog number, NDC, lot, expiration date, label, carton, barcode, or photograph that actually exists
- Names and contact information for the pharmacy, materials-management office, distributor, or other custodian that may hold purchasing, quarantine, return, replacement, or lot-reconciliation records, plus any such records lawfully provided
- Recall notices, patient notifications, facility responses, call logs, emails, letters, and B. Braun or FDA communications
- Accurate symptom, diagnosis, test, treatment, and follow-up records without adding a self-diagnosis
Common questions
What exactly does the recall cover?
FDA published the recall on August 28, 2026. Its summary lists August 27 as the company announcement date, while the body is datelined August 19. The recall covers B. Braun 0.9% Sodium Chloride Injection USP, 100 mL in a 150 mL PAB container, catalog S8004-5264, NDC 0264-1800-32, lots J6B435, J6B444, and J6B457, expiring 30APR2027. FDA says the recall reason was corrected on August 28 from zinc oxide to iron oxide. The product was distributed nationwide to hospitals and healthcare facilities from February 27 through August 3; those are distribution dates, not treatment-date limits.
What if the lot number is not in my chart?
Ask where pharmacy, barcode, preparation, inventory, purchasing, or distributor records are kept. A missing lot number in the chart does not prove that no separate lot-tracing record exists. It also does not prove that such a record exists or that recalled product was used.
Can I ask for my medical records?
HHS says people generally have access, with limited exceptions, to medical and billing records held by covered providers and plans. Internal inventory, quality, peer-review, or risk records may be separate from the ordinary chart.
Should I file a MedWatch report?
FDA accepts reports from patients and health professionals about suspected adverse events and product-quality problems. Reporting does not replace medical care or prove exposure, causation, defect, or responsibility.
Did FDA report injuries from these lots?
When FDA published the notice on August 28, it stated that, to date, there had been no reports of serious injury, death, or other adverse events associated with the issue. That fact and the recall status may later change.
Want more detail?
Read the full explanation
B. Braun IV Saline Recall: Records Patients Should PreserveOfficial resources
Questions about your situation?
Talk with Arta Wildeboer
A short guide cannot account for every fact. A free consultation can help you understand the next step without pressure.